Document Detail


Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.
MedLine Citation:
PMID:  23374117     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Sweden has been a pioneer in the treatment of haemophilia, with the first concentrate available in the 1950s. Treatment has improved over the years to its current state-of-the art. The aim of the current study was to evaluate the long-term outcome of haemophilia in terms of incidence, morbidity and mortality. Patients diagnosed with haemophilia A or B registered at the national haemophilia centres and/or the Patient Registry and born before 2009 and alive in 1968 were enrolled and linked to the Cause of Death-, Migration- and Medical Birth registries. Five age- and sex-matched controls were selected for each patient. A total of 1431 patients with haemophilia A or B were compared with 7150 controls. The 3-year moving average incidence rate per 100 000 population varied between 21 and 36. The hazard ratio for all-cause mortality compared with controls was 2.2, 95% CI: [1.8; 2.7], P < 0.001 for the entire group of patients and 1.7, 95% CI: [1.3; 2.2], P < 0.001 when patients with HIV and/or viral hepatitis were excluded. The corresponding figures for the severe haemophilia subgroup were 6.6, 95% CI: [4.5; 10.0], P < 0.001 and 8.2, 95% CI [3.2; 20.8], P < 0.001 respectively. The most common causes of death were related to malignancies and the haemostatic defect. People with haemophilia were 57% less likely to die from ischaemic heart disease than controls. People with haemophilia in Sweden demonstrate higher mortality over time, independent of HIV and viral hepatitis, despite relatively advantageous access to clotting factor concentrates.
Authors:
S Lövdahl; K M Henriksson; F Baghaei; M Holmström; J-Å Nilsson; E Berntorp; J Astermark
Related Documents :
23737347 - Pharmacokinetic interactions of cep-1347 and atazanavir in hiv-infected patients.
23596117 - Bone marrow findings in hiv-positive patients with kaposi sarcoma herpesvirus-associate...
23545227 - Hiv-associated lipodystrophy in south africa: the impact on the patient and the impact ...
15075497 - Mood and substance use disorders in older adults with hiv/aids: methodological issues a...
20037277 - Current status of liver diseases in korea: toxic and alcoholic liver diseases.
20058087 - Quality of life, characteristics and survival of patients with hiv and lymphoma.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-4
Journal Detail:
Title:  Haemophilia : the official journal of the World Federation of Hemophilia     Volume:  -     ISSN:  1365-2516     ISO Abbreviation:  Haemophilia     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9442916     Medline TA:  Haemophilia     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Blackwell Publishing Ltd.
Affiliation:
Department of Clinical Sciences, Clinical Coagulation Research Unit, Lund University, Skåne University Hospital, Malmö, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors associated with success of vaginal birth after one caesarean section (VBAC) at three teachin...
Next Document:  Target prioritization and strategy selection for active case-finding of pulmonary tuberculosis: a to...